Oaktree Specialty Lending...

15.49
-0.12 (-0.77%)
At close: Mar 28, 2025, 3:59 PM
15.50
0.03%
Pre-market: Mar 31, 2025, 06:43 AM EDT

Company Description

Oaktree Specialty Lending Corporation is a business development company specializing in investments in middle market, bridge financing, first and second lien debt financing, unsecured and mezzanine loan, mezzanine debt, senior and junior secured debt, expansions, sponsor-led acquisitions, preferred equity and management buyouts in small and mid-sized companies.

It seeks to invest in education services, business services, retail and consumer, healthcare, manufacturing, food and restaurants, construction and engineering, and media and advertising sectors.

It invests between $5 million to $75 million principally in the form of one-stop, first lien, and second lien debt investments, which may include an equity co-investment component in companies with enterprise value between $20 million and $150 million and EBITDA between $3 million and $50 million.

The fund has a hold size of up to $75 million and may underwrite transactions up to $100 million.

It primarily invests in North America.

The fund seeks to be a lead investor in its portfolio companies.

Oaktree Specialty Lending Corporation
Oaktree Specialty Lending Corporation logo
Country United States
IPO Date Jun 12, 2008
Industry Financial - Credit Services
Sector Financial Services
Employees 0
CEO Armen Panossian J.D.

Contact Details

Address:
333 South Grand Avenue
Los Angeles, California
United States
Website https://www.oaktreespecialtylending.com

Stock Details

Ticker Symbol OCSL
Exchange NASDAQ
Fiscal Year October - September
Reporting Currency USD
CIK Code 0001414932
CUSIP Number 67401P108
ISIN Number US67401P4054
Employer ID 26-1219283
SIC Code

Key Executives

Name Position
Armen Panossian J.D. Chief Executive Officer & Co-Chief Investment Officer
Christopher McKown MD,Chief Financial Officer & Treasurer
Ashley Pak Chief Compliance Officer
Dane Kleven Senior Vice President & Head of Investor Relations
Dr. Aman Kumar M.D. Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending
Lucia S. Kim Senior Vice President
Mary Gallegly J.D. MD,General Counsel & Secretary
Mathew M. Pendo President
Raghav Khanna Co-Chief Investment Officer
Sandeep Kumar Khorana Managing Director of Origination

Latest SEC Filings

Date Type Title
Mar 05, 2025 8-K Current Report
Feb 27, 2025 8-K Current Report
Feb 26, 2025 4 Filing
Feb 25, 2025 4 Filing
Feb 25, 2025 4 Filing
Feb 24, 2025 424B2 Filing
Feb 21, 2025 8-K Current Report
Feb 20, 2025 497AD Filing
Feb 20, 2025 FWP Filing
Feb 20, 2025 424B2 Filing